Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Her2-Positive Breast Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00448279
What this trial is testing

THOR Study: A Study of Continued Herceptin (Trastuzumab) in Combination With Second Line Chemotherapy in Patients With HER2 Positive Metastatic Breast Cancer.

Who this might be right for
Breast Cancer
Hoffmann-La Roche 58
Not applicableUnknownNCT03790813
What this trial is testing

Informative Tools to Optimize Neoadjuvant Therapy in ER Positive, HER2 Negative Breast Cancers

Who this might be right for
Breast Cancer
British Columbia Cancer Agency 50
Not applicableLooking for participantsNCT06708910
What this trial is testing

AI-based pCR Assessment/Prediction in HER2-Positive BC Using PET/MRI

Who this might be right for
HER2 Positive Breast Carcinoma
Heinrich-Heine University, Duesseldorf 460
Not applicableLooking for participantsNCT07095023
What this trial is testing

Neoadjuvant Oral Paclitaxel Plus Subcutaneous Pertuzumab/Trastuzumab in Patients With HER2-positive Breast Cancer

Who this might be right for
Breast Cancers
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 112
Not applicableLooking for participantsNCT07455188
What this trial is testing

A Study on the Efficacy and Safety of Switching Between Two Targeted Strategies, HP+Chemotherapy and HPy+Chemotherapy, After Treatment Progression in HER-2 Positive Advanced or Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Zhejiang Cancer Hospital 600
Not applicableStudy completedNCT01928186
What this trial is testing

FLT PET in Measuring Treatment Response in Patients With Newly Diagnosed Estrogen Receptor-Positive, HER2-Negative Stage I-III Breast Cancer

Who this might be right for
Estrogen Receptor PositiveHER2/Neu NegativeMale Breast Carcinoma+7 more
University of Washington 28
Large-scale testing (Phase 3)Study completedNCT00567190
What this trial is testing

Evaluate Pertuzumab + Trastuzumab + Docetaxel vs. Placebo + Trastuzumab + Docetaxel in Previously Untreated HER2-Positive Metastatic Breast Cancer

Who this might be right for
Metastatic Breast Cancer
Genentech, Inc. 808
Testing effectiveness (Phase 2)UnknownNCT05255523
What this trial is testing

Pyrotinib Plus Trastuzumab After First-line TH (P) Treatment With HER-2 Positive Breast Cancer

Who this might be right for
Advanced Breast Cancer
Fujian Medical University Union Hospital 60
Not applicableLooking for participantsNCT06754059
What this trial is testing

Pyrotinib Combined With Trastuzumab for Maintenance Therapy After First-line TH (P) Therapy for HER2+ABC

Who this might be right for
HER2-positive Breast Cancer
zhangjie 60
Testing effectiveness (Phase 2)Looking for participantsNCT07276880
What this trial is testing

Preoperative Chemotherapy, Pembrolizumab and Low or High Dose RADiation in an Expansion Cohort of Node(+), Triple Negative Breast Cancer

Who this might be right for
Breast CancerTriple Negative Breast Cancer (TNBC)HER2-Negative Breast Carcinoma+1 more
UNC Lineberger Comprehensive Cancer Center 32
Large-scale testing (Phase 3)Looking for participantsNCT03418961
What this trial is testing

S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity

Who this might be right for
CardiotoxicityHER2/Neu PositiveMetastatic Malignant Neoplasm in the Brain+2 more
SWOG Cancer Research Network 491
Early research (Phase 1)Looking for participantsNCT04332588
What this trial is testing

Monitoring HER2+ Breast Cancer Neoadjuvant Treatment With Advanced PET/MRI

Who this might be right for
HER2-positive Breast Cancer
University of Alabama at Birmingham 25
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07217990
What this trial is testing

Neoadjuvant Complete Response Customized Treatment Approach for Definitive Management of Breast Cancer

Who this might be right for
Breast CancerHER2-positive Breast CancerTriple Negative Breast Cancer
Ohio State University Comprehensive Cancer Center 84
Testing effectiveness (Phase 2)Looking for participantsNCT06832904
What this trial is testing

Neoadjuvant Chemotherapy Plus Pyrotinib and Trastuzumab for HER2-positive Breast Cancer (NEOTORCH-BREAST05)

Who this might be right for
HER2-positive Breast CancerNeoadjuvant TherapyPyrotinib
First Affiliated Hospital of Zhejiang University 33
Early research (Phase 1)Study completedNCT00470847
What this trial is testing

Lapatinib in Combination With Radiation Therapy in Patients With Brain Metastases From HER2-Positive Breast Cancer

Who this might be right for
Breast CancerBrain Metastases
Nancy Lin, MD 35
Large-scale testing (Phase 3)Active Not RecruitingNCT06968585
What this trial is testing

A166 Versus Trastuzumab Emtansine (T-DM1) in Patients With HER2-Positive Unresectable or Metastatic Breast Cancer Previously Treated With Trastuzumab and Taxane Therapy

Who this might be right for
HER2-positive Breast Cancer
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. 365
Not applicableLooking for participantsNCT06711055
What this trial is testing

Taxane Combined Targeted Therapy for Low-risk HER2 Positive and Lymph Node Negative Breast Cancer

Who this might be right for
HER2-positive Breast Cancer
Shu Wang 285
Testing effectiveness (Phase 2)Looking for participantsNCT07666555
What this trial is testing

A Phase II Clinical Study of the Efficacy and Safety of Culmerciclib Rechallenge in HR-positive, HER2-negative Breast Cancer Patients With Resistance to First-line Endocrine Therapy.

Who this might be right for
Breast Cancer
Fudan University 98
Not applicableUnknownNCT03908749
What this trial is testing

A Real-world Clinical Study of Pyrotinib Maleate Tablets in the Treatment of Breast Cancer Patients With Positive Her-2

Who this might be right for
HER2 Positive Breast Carcinoma
Anhui Provincial Hospital 300
Not applicableUnknownNCT05063643
What this trial is testing

Cardiotoxicity of Targeted Therapy for HER-2 Positive Breast Cancer Patients at High Altitude

Who this might be right for
HER2-positive Breast CancerTargeted TherapyCardiac Toxicity+1 more
Affiliated Hospital of Qinghai University 132
Next Page